FIELD: pharmaceuticals.
SUBSTANCE: invention refers to specific compounds for inhibiting FASN.
EFFECT: obtaining novel compounds capable of inhibiting FASN.
7 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | 2014 |
|
RU2686323C2 |
| COMPOSITIONS CONTAINING BENZOPIPERAZINE AS BROMODOMAIN BET INHIBITORS | 2014 |
|
RU2720237C2 |
| POLYCYCLIC COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF POLYPEPTIDES OF FAST ACCELERATED FIBROSARCOMA | 2019 |
|
RU2830173C2 |
| P38 INHIBITORS AND APPLICATION METHODS | 2004 |
|
RU2357957C2 |
| COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
| MAGL INHIBITORS | 2017 |
|
RU2754536C1 |
| HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USE THEREOF | 2016 |
|
RU2743360C2 |
| COMPOUNDS WITH CONDENSED RINGS | 2019 |
|
RU2783414C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| INDOL-3-YL-CARBONYL-PIPERADINE-BENZIMIDAZOLE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415139C2 |
Authors
Dates
2020-11-30—Published
2014-03-11—Filed